- Home
- NSRX
NSRX
Nasus Pharma Ltd. Ordinary Shares
as 10-24-2025 3:55pm EST
| Founded: | 2019 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 73.0M | IPO Year: | 2025 |
| Target Price: | $22.00 | AVG Volume (30 days): | 5.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $9.99 | Next Earning Date: | 11-20-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nasus Pharma Ltd. Ordinary Shares News
NSRX Breaking Stock News: Dive into NSRX Ticker-Specific Updates for Smart Investing
Compare NSRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NSRX Nasus Pharma Ltd. Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.